Immunotherapy Targeting Plasma ASM Is Protective in a Mouse Model of Alzheimer’s Disease

Researchers explored plasma acid sphingomyelinase (ASM) as a circulating factor that accelerates neuropathological features in Alzheimer’s disease by exposing young APP/PS1 mice to the blood of mice overexpressing ASM, through parabiotic surgery.